| Standard not met | Reason | Action being taken by the Pharmacy | By when | Notification By Pharmacy Improvements Made |
|---|---|---|---|---|
| 1.1 | The pharmacy team are able to verbally explain the considerations they carry out to manage some of the risks in the services they provide. And the pharmacy has a basic risk assessment for the supply of weight loss medicines, and for the sale of Pharmacy Only (P) medicines. But it does not have an overarching written risk assessment that shows how it has considered and mitigated all of the risks of the model it is using including the overall risks of the service and ensuring appropriate records are kept. And the pharmacy doesn’t have a risk assessment for the supply of salbutamol inhalers. The pharmacy does not fully follow its own procedures for the supply of P medicines. |
For the supply of P medicines, we have implemented some changes to show the approval of each P item that is supplied. This is reflected in the changes we have made to the SOP for supply of P and GSL in section 13. This change should ensure safe and effective supply of P medicines alongside record keeping. With the addition of this section there are clear instructions for the RP and pharmacy team on the supply of medicines. An overall risk assessment has been completed. A risk assessment and SOP has been done for the supply of salbutamol inhalers. In the SOP for prescribing in weight loss, a section has been added with instructions and guidance on how to record prescribing decisions. |
22/05/2025 | 22/05/2025 |
| 1.6 | The pharmacy cannot show that it keeps all the records it needs to for the safe provision of its services. The prescriber does not routinely record prescribing decisions for the weight management service. And the pharmacy does not routinely record the reasons it has sold P medicines, particularly for medicines liable to abuse, misuse or overuse. |
To show clear and concise records for products supplied in regard to weight management we have added a section to the SOP. This section mentions the need for and importance of record making in the safe provision of medication. The pharmacy team have had a meeting to discuss how to improve the record making part of the consultation. We have gone through our learnings from the Independent prescribing course and the weight loss training we attended. Furthermore, we have sought guidance from fellow prescribing practitioners to improve in this area. When making a prescribing decision, the reason will be stated for each consultation which will be kept on the patient record. With regards to the P medicines, as mentioned previously for standard 1.1, the responsible pharmacist will go through each order as they normally do, but they will routinely add a note regarding the approval of P medicines, especially the ones that can be misused. |
22/05/2025 | 22/05/2025 |
Pharmacy inspections
Inspection reports and learning from inspections